Responsiveness and Convergent Validity of a New Patient-Reported Outcome Measure for Chronic Rhinosinusitis (CRS-PRO)

BACKGROUND: The CRS-PRO is a new patient-reported outcome measure (PROM) for chronic rhinosinusitis (CRS) that was developed using extensive patient input per Food and Drug Administration guidance on PROMs acceptable for use as end points in clinical trials. OBJECTIVE: To assess the responsiveness a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol Pract
Main Authors: Ghadersohi, Saied, Price, Caroline P.E., Beaumont, Jennifer L., Kern, Robert C., Conley, David B., Welch, Kevin C., Calice, Alexis M., Stanton, Elizabeth, VanderMeeden, Marisa K., Jensen, Sally E., Peters, Anju T., Grammer, Leslie C., Stevens, Whitney W., Schleimer, Robert P., Tan, Bruce K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448959/
https://ncbi.nlm.nih.gov/pubmed/32361009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.04.031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados